Please enable Javascript
Sara Nunnery, MD, MSCI
Sara Nunnery, MD, MSCI
Sara Nunnery, MD, MSCI, is director of breast cancer research at Tennessee Oncology.
Articles by Sara Nunnery, MD, MSCI
Trastuzumab Deruxtecan in HER2-Low Breast Cancer: Who’s the Right Patient?
Sara Nunnery, MD, MSCI
HER2 Breast Cancer
|
May 1, 2025
Dr. Nunnery weighs IV Enhertu vs oral chemo, highlighting how patient goals and QoL shape treatment decisions.
View More
Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer
Sara Nunnery, MD, MSCI
HER2 Breast Cancer
|
May 6, 2025
Dr. Nunnery discusses HER2-low and ultralow testing and Enhertu’s role after DESTINY-Breast06 in metastatic breast cancer.
View More